Apogee Therapeutics, Inc. APGE 深 沪
交易中 05-11 10:32:44 美东时间
87.80
+5.120
+6.19%
华盛通- 最 高88.01
- 今 开83.99
- 成交量 8.19万股
- 最 低 80.83
- 昨 收 82.68
- 总市值 0
- 52周最高 95.315
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 34.34
- 委 比 -75.00%
- 总股本 --
- 历史最高 95.315
- 量 比 1.54
- 振 幅 8.68%
- 历史最低 14.19
- 每 手 1
- 风险率 17.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Apogee Announces $300M Stock Offering
In addition, Apogee expects to grant the underwriters a 30-day option to purchase up to an additional $45 million of shares of its common stock at the public offering price, less underwriting discounts and commissions.
03-24 04:02
Crude Oil Falls Sharply; Dell Shares Spike Higher
Dow up 2.45%, Nasdaq up 2.46%, S&P 500 up 2.19%. Consumer discretionary shares up 3.6%, energy stocks up 0.3%. Dell announces enhancements, BofA raises price target. Apogee up 17%, Tower Semi up 9%, Urban-gro up 46%. Atlantic Int'l down 13%, Linkers down 85%, Valneva down 37%. Oil down 8.1%, gold down 2.1%. European and Asian markets mixed.
03-24 03:15
Apogee Therapeutics Stock Rallies On Encouraging Eczema Drug Data Readout
Apogee Therapeutics stock jumps on 52-week eczema data; durable response supports Phase 3 plans later in 2026.
03-23 22:04
Apogee Therapeutics Q4 EPS $(1.03) Beats $(1.04) Estimate
Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate of $(1.04) by 1.25 percent. This is a 13.45 percent increase over losses of $(1.19) per share
03-02 20:27
Apogee Therapeutics Begins Dosing Volunteers in Phase 1 Atopic Dermatitis Trial
08:43 AM EDT, 08/19/2024 (MT Newswires) -- Apogee Therapeutics (APGE) said Monday it has dosed the first participants for the phase 1 trial of APG990, the company's investigative subcutaneous treatment for atopic dermatitis. Apogee said it expects interim data from the trial in 2025. Shares of the c...
2024-08-19 20:43
